Objective:To investigate the effects of PRR11 on lipase H, immunomodulator and Survivin levels in thyroid cancer cells.Methods:A retrospective analysis was performed on 30 patients (13 males and 17 females) who received surgery for thyroid cancer in the Department of Thyroid Surgery of Yantai Yantaishan Hospital from Jun. 2020 to Oct. 2022. According to the study protocol, normal thyroid epithelial cells were used as the control group, and SW579 thyroid cancer cells were divided into no-load group, PRR11 up-regulated group and PRR11 down-regulated group. SW579 cell proliferation was detected by MTT assay and the levels of TNF- a, IL-1 β and IL-6 were detected by enzym-linked immunosorbent assay (ELISA). Apoptosis of SW579 cells and expressions of CD4+CD25+ and CD8+CD28- were detected by flow cytometry, and Survivin protein expression was detected by western blot analysis. Results:The mrna expression level of PRR11in thyroid carcinoma tissues (1.54±0.34) was significantly higher than that in para-carcinoma tissues (1.02±0.54) and normal thyroid epithelial cell line NTHY-ORI 3-1 (1.02±0.65) ( P<0.05). The mRNA expression level of PRR11 in SW579 (2.54±0.87) was higher than that in K1 CELL (1.74±0.45) and IHH-4 CELL (1.86±0.55) ( P<0.05), so SW579 was selected as the experimental cell. The expressions of SW579 cell proliferation, apoptosis, LIPH, TNF-α, IL-1β, IL-6, CD4+CD25+, CD8+CD28- and Survivin were significantly lower than those of no-load group ( P> 0.05), but higher than those of no-load group ( P<0.05). SW579 cell apoptosis rate, CD4+CD25+, CD8+CD28- ratio decreased ( P<0.05). The proliferation rate, LIPH (6.45±1.34), TNF-α (1.85±0.36), IL-1β (96.47±6.44), IL-6 (1.43±0.86) and Survivin protein expression of SW579 cells in PRR11 down-regulated group were lower than those in control group and no-load group ( P<0.05). The apoptosis rate, CD4+CD25+ and CD8+CD28- of SW579 cells were higher than those of control group and no-load group ( P<0.05) . Conclusion:Down-regulation of PRR11 can reduce the expression of LIPH, regulate the level of immunomodulator and Survivin, enhance the body's immunity, inhibit the proliferation and promote the apoptosis of thyroid cancer cells, and provide a new strategy for the diagnosis, treatment and prognosis of thyroid cancer.

BACKGROUND:Stem cells have been shown to not only replace damaged cells, but also secrete trophic factors, bringing a bright future for the treatment of clinical spinal cord injury.
OBJECTIVE:To review the latest advances of bone marrow mesenchymal stem cells in animal and clinical research.
METHODS:A computer-based search of Kjmed and Wanfang databases was done for relevant articles published from April 2004 to April 2014 using the keywords of“stem cells, spinal cord injuries, embryonic stem cells, neural stem cells, mesenchymal stem cells”in English and Chinese, respectively.
RESULTS AND CONCLUSION:Total y 2 745 articles were initial y retrieved, and only 50 articles were included in result analysis. Bone marrow mesenchymal stem cells have become one of the most promising sources of stem cells in the treatment of spinal cord injury. Although the bone marrow mesenchymal stem cellin the treatment of spinal cord injury is stil in its infancy, it has certain effects on the repair of spinal cord injury. The mechanism of action of bone
marrow mesenchymal stem cells in the treatment of spinal cord injury is possibly related to the substitution effect, neurotrophic effects, suppression of the immune response and promoting axonal regeneration.

Objective To investigate the methods of reducing radiation dose in CT coronary angiography through optimizing individualized scan dosage protocol.Methods Two hundred patients (group A)underwent coronary CTA examination which was performed with fixed 120 kV and variable mA according to their BMI.The mA was set as 150-300 mA(BMI ＜ 18.5 kg/m2),300-500 mA (18.5 kg/m2 ≤ BMI ＜ 25.0 kg/m2),and 500-800 mA(BMI ≥ 25.0 kg/m2).When all examinations were finished,a linear regression was employed to analyze the correlation between mA and BMI,body surface(Suf),image noise(SD)respectively.The results of the analysis were used to formulate a regression equation,which was further used to establish a table list for quick search on how much mA that individualized coronary CTA scan would need.Another 200 patients(group B)enrolled for the individualized scan were scanned under new protocol that previous study established.The tube voltage was 100 and 120 kV.The tube current was variable according to the data in the table list.One-way ANOVA and Kruskal-wallis H test were used for statistics.Results Regression equation between mA and BMI,Suf,SD was:mA =17.984 × BMI + 169.149 × Suf-2.282 × SD-361.039.The SD(group A:32.08 ± 5.80,group B:28.60±4.47),dose index volume(CTDIvol)[group A:(41.97 ± 11.37)mGy,group B:(33.18±10.07)mGy],effective dose(ED)[group A:(10.91 ±3.07)mSy,group B:(8.83 ±2.72)mSv]had significant differences between the two groups(F =43.45,63.71,49.07 respectively,P ＜0.01 for all).The SD and ED results obtained in group B were better than those in group A.Conclusion Better performances were obtained when BMI combined Suf was used as a new individualized protocol than when BMI was used only,which means good image quality and lower radiation dosage in coronary CTA examination.

Objective To study the efficacy of rituximab in the treatment of pemphigus vulgaris (PV) and its underlying mechanism. Methods A 38-year-old female with PV presented with refractory, painful oral ulcers and erosions. Since she was poorly responsive to prednisone 80 mg daily, intravenous ritu-ximab of 500 mg once a week was given for successive 3 weeks followed by 5 successive days of intra-venous gamma globulin at a dose of 400 mg/kg per day, and a total of two treatment sessions were conducted. ELISA was used to detect the serum titer of anti-Dsg3 antibodies and their IgG subtypes (IgG1 and IgG4) as well as serum level of interferon-gamma (IFN-gamma), interleukin-4 (IL-4), interleukin-10 (IL-10). Results Three months after the end of two treatment sessions, the symptom was obviously improved, and lesions subsided; alter another 1 month, clinical symptom fully disappeared. During the 1-year follow-up, no lesions recurred. The anti-Dsg3 antibody titer was 253.33 U/mL before treatment, plateaued at 250 U/mL within 4 weeks after the initial infusion, decreased till 3 months after the withdrawal, and reached 26.06 U/mL 7 months after the withdrawal, and remained within normal range till the time of this writing. The serum titer of IgGl subclass of anti-Dsg3 antibodies dropped dramatically fight after the first infusion, but that of IgG4 subclass remained at a high level at early stage of medication, began to decline until 3 months after the with-drawal, and finally reached the normal range following clinical remission. Also, serum level of IFN-garnma and IL-10 correlated with the severity of PV. Conclusions Combined rituximab is effective for the control of PV, likely by eliminating Dsg3-specific antibodies, especially IgG4 subclass of them.

Samples of healthy and full-term human umbilical cord blood samples were obtained asceptically. Mesenchymal stem cells (MSCs) were isolated by lymphocyte separation medium, and were characterized morphologically by fluorescence-activated cell sorting analysis. Differentiation of chondroblast and osteoblast was induced by 10 ng/ml TGF-beta, 100 ng/ml insulin and 10(-7) mol/L decaesadril, 6.25 microg/ml siderophilin, 10 mmol/L beta-sodium glycerophosphate, 50 microg/ml antiscorbic acid, respectirely; the aim was to investigate the potentiality of differentiation. Umbilical cord blood-derived MSCs were stained positive for MSCs marker CD13, CD90, CD166, CD73, CD44 and HLA-AB, but were negative for hematopoietic stem cell marker CD45, CD34 and HLA-DR. After 21 days induction, Toluidine Blue staining and von-Kossa staining were positive. Immunocytochemistry showed that Collagen II expressed in the induced cells. The results demonstrated that mesenchymal stem cells can be isolated from human umbilical cord blood and differentiated into chondroblasts and osteoblasts in vitro.
Cell Differentiation ; Cell Separation ; Cells, Cultured ; Chondrocytes ; cytology ; Fetal Blood ; cytology ; Humans ; Mesenchymal Stromal Cells ; cytology ; Osteoblasts ; chemistry

AIM: To isolate the stem cells from human placenta and induce them into cardiomyocytes. METHODS: Stem cells were isolated from human placenta and characterized by morphologic analysis. The “hanging drop” methods were used to inducte stem cells into cardiomyocytes. The expressions of atrial natriuretic factor(Anf) and ?-myosin heavy chain(?-MHC) genes were analyzed by RT-PCR. RESULTS: Stem cells derived from human placenta were self-renewed and differentiated into cardiomyocytes in vitro. RT-PCR showed that Anf and ?-MHC genes were expressed in the “beating cells”.CONCLUSION: Human placenta is an abundant source of stem cells.